Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stewart Wang

Plastic Surgery Pasadena, CA Medical Doctor

NPI 1306878491 CMS profile 331214

76 N Hudson Ave Ste 100, Pasadena, CA 91101

Open in the dashboard

General payments

$7,112

88 records reported · program years 2019–2025

Research payments

$342

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stewart Wang of Pasadena, CA is reported in the CMS Open Payments database as having received $7,112 across 88 general payments and $342 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,090 17
2025 Research $342 1
2024 General $1,180 14
2023 General $1,599 17
2022 General $1,374 16
2021 General $1,786 17
2020 General $16 1
2019 General $68 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stewart Wang
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Stewart Wang were reported at $1,090. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Stewart Wang Plastic Surgery median Middle half National median
2019 $68 $371 $122–$1,483 $163
2020 $16 $158 $52–$438 $114
2021 $1,786 $249 $87–$752 $132
2022 $1,374 $274 $102–$793 $149
2023 $1,599 $299 $113–$891 $160
2024 $1,180 $361 $124–$1,062 $164
2025 $1,090 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $4,056 36 payments
  2. AbbVie, Inc. $2,929 43 payments
  3. Revance Therapeutics, Inc. $43 2 payments
  4. Galderma Laboratories, L.P. $32 2 payments
  5. Avanos Medical $20 1 payment
  6. Apyx Medical Corporation $18 3 payments
  7. Sientra, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,264 45 payments
  2. Food and Beverage $847 43 payments
Products named General payments · program years 2019–2025
  1. BOTOX $235 7 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $81 5 payments
  3. NATRELLE $66 4 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $56 6 payments
  5. DAXXIFY $43 2 payments
  6. ON-Q* PUMP AND ACCESSORIES $20 1 payment
  7. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $13 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Davol Inc. $342 1 payment

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record